Exerte Partners

About

Portfolio · 1

OCON Therapeutics

Spherical Intrauterine Drug Delivery Platform

1 round $10.0M committed Latest: 2024-06

Investment activity

Q&A

What is Exerte Partners' most recent investment?

Exerte Partners most recently invested in OCON Therapeutics, participating in a $24.5M Series A round in June 2024.

What is Exerte Partners' primary sector focus?

Exerte Partners has shown a focus on the Health Tech & Life Sciences sector, with its only recorded investment being in OCON Therapeutics.

What stage of funding does Exerte Partners typically participate in?

Exerte Partners has participated in a Series A round, specifically investing in OCON Therapeutics.

Can you name a notable company in Exerte Partners' portfolio?

A notable company in Exerte Partners' portfolio is OCON Therapeutics, which develops a Spherical Intrauterine Drug Delivery Platform.

Where is Exerte Partners headquartered?

Exerte Partners is headquartered in Greece.

What is the investment range for Exerte Partners?

Exerte Partners' investment range is $10M - $10M.